RecruitingNCT03420339
Stimulant medicines and disruptive behavior in young people
About this title
Read the official source — NCT03420339Medication studyAges 48 months–12 yearsUnited StatesADHD
Understand this study
Who could participate?
Listed age limits: 48 months to 12 years.
- Listed locations
- Iowa CitySee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2018
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- Matthew J O'Brien, PhD, BCBA-D
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 48 Months to 12 Years
- Official registry ID
- NCT03420339
- Official title
Show the full official title
The Effects of Stimulant Medication on Disruptive Behavior, Choice, and Preference in Children and Adolescents Exhibiting Disruptive Behavior
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Iowa City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Matthew J O'Brien, PhD, BCBA-D.
Does this study involve medication?
Yes. The study involves medication, including Stimulant.
Who can participate?
Listed age limits: 48 months to 12 years.
Is this study still recruiting?
The registry lists this study as recruiting.
